139 related articles for article (PubMed ID: 28294419)
1. Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study.
Moscarella E; Argenziano G; Longo C; Aladren S
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e401-e403. PubMed ID: 28294419
[No Abstract] [Full Text] [Related]
2. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effects of Sunscreens Alone vs Sunscreens Plus DNA Repair Enzymes in Patients With Actinic Keratosis: Clinical and Molecular Findings from a 6-Month, Randomized, Clinical Study.
Carducci M; Pavone PS; De Marco G; Lovati S; Altabas V; Altabas K; Emanuele E
J Drugs Dermatol; 2015 Sep; 14(9):986-90. PubMed ID: 26355618
[TBL] [Abstract][Full Text] [Related]
4. The use of a sunscreen containing DNA-photolyase in the treatment of patients with field cancerization and multiple actinic keratoses: a case-series.
Navarrete-Dechent C; Molgó M
Dermatol Online J; 2017 Jan; 23(1):. PubMed ID: 28329483
[TBL] [Abstract][Full Text] [Related]
5. A 9-month, randomized, assessor-blinded, parallel-group study to evaluate clinical effects of film-forming medical devices containing photolyase and sun filters in the treatment of field cancerization compared with sunscreen in patients after successful photodynamic therapy for actinic keratosis.
Eibenschutz L; Silipo V; De Simone P; Buccini PL; Ferrari A; Carbone A; Catricalà C
Br J Dermatol; 2016 Dec; 175(6):1391-1393. PubMed ID: 27167413
[No Abstract] [Full Text] [Related]
6. Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial.
Alvares BA; Miola AC; Schimitt JV; Miot HA; Abbade LPF
An Bras Dermatol; 2022; 97(2):157-165. PubMed ID: 35039206
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
[TBL] [Abstract][Full Text] [Related]
8. A Novel Technology: Sunscreen With Actinic Damage Repair.
Kircik Md LH
J Drugs Dermatol; 2017 May; 16(5):s59-s60. PubMed ID: 28628692
[No Abstract] [Full Text] [Related]
9. Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis.
Bobyr I; Campanati A; Giacchetti A; Offidani A
Photodermatol Photoimmunol Photomed; 2019 Jul; 35(4):277-279. PubMed ID: 30690758
[No Abstract] [Full Text] [Related]
10. The efficacy of a photolyase-based device on the cancerization field: a clinical and thermographic study.
Laino L; Elia F; Desiderio F; Scarabello A; Sperduti I; Cota C; DiCarlo A
J Exp Clin Cancer Res; 2015 Aug; 34(1):84. PubMed ID: 26282842
[TBL] [Abstract][Full Text] [Related]
11. What's New in Photoprotection: A Review of New Concepts and Controversies.
Yeager DG; Lim HW
Dermatol Clin; 2019 Apr; 37(2):149-157. PubMed ID: 30850037
[TBL] [Abstract][Full Text] [Related]
12. Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial.
Neittaanmäki-Perttu N; Grönroos M; Karppinen TT; Tani TT; Snellman E
Br J Dermatol; 2016 Feb; 174(2):427-9. PubMed ID: 26011755
[No Abstract] [Full Text] [Related]
13. Swiss clinical practice guidelines on field cancerization of the skin.
Hofbauer G; Anliker M; Boehncke WH; Brand C; Braun R; Gaide O; Hafner J; Hunger R; Itin P; Kaeuper G; Lautenschlager S; Mainetti C; Streit M
Swiss Med Wkly; 2014; 144():w14026. PubMed ID: 25539459
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
15. Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study.
Babino G; Diluvio L; Bianchi L; Orlandi A; Di Prete M; Chimenti S; Milani M; Campione E
Curr Med Res Opin; 2016 Aug; 32(8):1345-9. PubMed ID: 27046744
[TBL] [Abstract][Full Text] [Related]
16. Actinic keratosis: do the numbers add up?
Stanger CB
Nurse Pract; 2009 Feb; 34(2):36-9. PubMed ID: 19155885
[No Abstract] [Full Text] [Related]
17. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study.
Szeimies RM; Radny P; Sebastian M; Borrosch F; Dirschka T; Krähn-Senftleben G; Reich K; Pabst G; Voss D; Foguet M; Gahlmann R; Lübbert H; Reinhold U
Br J Dermatol; 2010 Aug; 163(2):386-94. PubMed ID: 20518784
[TBL] [Abstract][Full Text] [Related]
18. Dermoscopy and methyl aminolevulinate: A study for detection and evaluation of field cancerization.
Rossi A; Garelli V; Pranteda G; Cardone M; Anzalone A; Fortuna MC; Di Nunno D; Mari E; De Vita G; Carlesimo M
J Photochem Photobiol B; 2016 Sep; 162():72-76. PubMed ID: 27344021
[TBL] [Abstract][Full Text] [Related]
19. Tretinoin (0.05% cream vs. 5% peel) for photoaging and field cancerization of the forearms: randomized, evaluator-blinded, clinical trial.
Sumita JM; Miot HA; Soares JLM; Raminelli ACP; Pereira SM; Ogawa MM; Picosse FR; Guadanhim LRS; Enokihara MMSS; Leonardi GR; Bagatin E
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1819-1826. PubMed ID: 29704456
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
